Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients

Fig. 3

Nomogram for predicting the risk of BRCA1/2 germline mutation in Chinese bilateral breast cancer patients. (A) Nomogram model. (B) The accuracy of nomogram in BRCA1/2 germline mutation prediction is assessed by ROC curve, which shows good performance (Area under curve, 0.828). (C) The calibration curve of the nomogram in predicting BRCA1/2 germline mutation

Back to article page